Human mpox (monkeypox) is an infection characterized by rash and fever. Mpox has historically been reported in Central and Western Africa, and in early 2022, additional cases were identified in Europe and North America. By late November 2022, more than 80,000 cases had been identified in 110 countries, most of which had never previously reported the infection.
Learning Resources — HIV/STI Treatment and Prevention
PrEP Action Kit (Updated 2023)
This PrEP Action Kit includes clinical resources to help providers incorporate PrEP into their practices. Including helpful resources such as tips on taking a comprehensive sexual history, frequently asked questions about PrEP and information on PrEP prescribing and monitoring. This action kit is an essential resource for all providers treating LGBTQIA+ patients or patients at risk of HIV infection.
Financing PrEP in the Current Era
In this webinar, Dr. Kevin Ard discussed recent developments in the field of PrEP, such as licensure of long-acting injectable medication for HIV pre-exposure prophylaxis (PrEP), availability of a generic PrEP formulation, and concerns about the 340B program. These developments have led to questions about financing PrEP in 2023 and beyond. In this interactive session, experts on PrEP will discuss the current PrEP financing landscape and what may be in store for the future.
- Filed under
- Pre-Exposure Prophylaxis (PrEP)
Promoting Health Equity for Black Transgender MSM in HIV Prevention, Treatment, and Access
Join us for a fireside chat with Dr. Tonia Poteat, PhD, PA-C, MPH from the UNC Center for Health Equity Research and Deborah Dunn where they discuss the importance of promoting health equity for Black Trans MSM seeking HIV prevention, treatment or testing. Topics include, but are not limited to discussing the effects of racism, transphobia, and other risk factors that contribute to medical mistrust in the Black and Trans community, as well as, the unique sexual and reproductive health needs of Black Trans MSM.
HIV and Monkeypox
In this webinar, Dr. Kevin Ard will discuss monkeypox and HIV. In the 2022 global monkeypox outbreak, people with HIV represented approximately 40% of those with monkeypox. In this clinically-focused webinar, participants will learn up-to-date information about the epidemiology, manifestations, testing, treatment, and prevention of monkeypox, with a focus on care for those with or at risk for HIV.
- Filed under
- HIV/STI Treatment and Prevention
PrEP and Transgender Communities: Evidence Informed Practices
This talk is from the 2022 Advancing Excellence in Transgender Health Care Conference.
HIV Care for Transgender and Gender Diverse People
This talk is from the 2022 Advancing Excellence in Transgender Health Care Conference.
Innovative Models for HIV Prevention and Care
In this interactive webinar, participants will learn about novel approaches to HIV prevention and care, including status-neutral care paradigms, same-day pre-exposure prophylaxis (PrEP), and rapid antiretroviral start programs. The webinar will also provide up-to-date information about how to implement long-acting injectable PrEP at health centers.
Meningococcal Disease Outbreak among Men Who Have Sex with Men in Florida: Background, Response, and Vaccination Recommendations
This collaborative webinar with the Centers for Disease Control & Prevention will focus on the ongoing outbreak of serogroup C meningococcal disease in Florida, mostly among men who have sex with men. Experts will provide background on meningococcal disease, an overview of the outbreak and the related response, and recommendations for vaccination.
- Filed under
- HIV/STI Treatment and Prevention
Long-Acting Injectable PrEP for HIV: What Health Centers Need to Know
Long-acting injectable cabotegravir was approved for HIV pre-exposure prophylaxis in late 2021. In this interactive webinar, participants will learn about the effectiveness, advantages, and disadvantages of long-acting injectable cabotegravir as well as the clinical and programmatic steps to incorporate it into practice.
- Filed under
- Pre-Exposure Prophylaxis (PrEP)
